San Mateo-based Mousera recently raised $20 million, according to an SEC filing, bringing the company’s total funding to date to at least $28.8 million. Existing investors include Lux Capital, Founders Fund, Data Collective, AME Cloud Ventures, and Dolby Family Ventures.
The stealthy startup is developing a tool that helps biomedical investigators accelerate the preclinical drug discovery and development pipeline. Using Mousera’s service, researchers will be able to design, run and analyze experiments with high volumes of data; the results will be more predictive of how drugs perform in humans.
The company was co-founded and headed by Timothy L. Robertson, who previously held a post of VP of Product Applications at Proteus Digital Health. Proteus offers a medication management and adherence system that includes sensor-laden pills, a peel-and-stick biometric sensor patch, and companion smartphone apps.
Mousera raised its last round in October 2014.
[Via: mobihealthnews]